Comparison of Once-Daily Bemiparin with Twice-Daily Enoxaparin for Acute Deep Vein Thrombosis: A Multicenter, Open-Label, Randomized Controlled Trial

Authors:

Abstract
Individuals with deep vein thrombosis (DVT) have an increased risk of pulmonary embolism (PE), death, and long-term thrombotic complications.
Funding Information
  • This study was funded by Berlin-Chemie AG. Medical writing assistance was funded by Berlin-Chemie AG and Laboratorios Farmaceuticos Rovi S.A.

This publication has 27 references indexed in Scilit: